Organon & Co. financial data

Symbol
OGN on NYSE
Location
30 Hudson Street, Fl 33, Jersey City, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 166 % +2.79%
Quick Ratio 50.6 % +7.19%
Debt-to-equity 2.24K %
Return On Equity 125 %
Return On Assets 5.33 % -37.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 260M shares +0.97%
Common Stock, Shares, Outstanding 260M shares +0.97%
Entity Public Float 5.3B USD 0%
Common Stock, Value, Issued 3M USD 0%
Weighted Average Number of Shares Outstanding, Basic 260M shares +1.03%
Weighted Average Number of Shares Outstanding, Diluted 260M shares +0.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.28B USD -1.02%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 666M USD +1.68%
Income Tax Expense (Benefit) -34M USD +90.1%
Net Income (Loss) Attributable to Parent 700M USD -30%
Earnings Per Share, Basic 2 USD/shares -30.3%
Earnings Per Share, Diluted 2 USD/shares -30.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 599M USD -14.9%
Accounts Receivable, after Allowance for Credit Loss, Current 1.48B USD -8.23%
Inventory, Net 1.45B USD +13%
Other Assets, Current 1.08B USD +20%
Assets, Current 4.62B USD +2.42%
Property, Plant and Equipment, Net 1.27B USD +8.95%
Operating Lease, Right-of-Use Asset 157M USD -9.25%
Goodwill 4.68B USD +1.67%
Assets 13.5B USD +11.1%
Accounts Payable, Current 1.07B USD -14.2%
Liabilities, Current 2.8B USD +1.49%
Deferred Income Tax Liabilities, Net 69M USD +15%
Operating Lease, Liability, Noncurrent 112M USD -10.4%
Other Liabilities, Noncurrent 1.12B USD +105%
Liabilities 12.8B USD +6.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -572M USD +6.54%
Retained Earnings (Accumulated Deficit) 1.16B USD +68.6%
Stockholders' Equity Attributable to Parent 733M USD +409%
Liabilities and Equity 13.5B USD +11.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 75M USD -1.32%
Net Cash Provided by (Used in) Financing Activities -75M USD -1.35%
Net Cash Provided by (Used in) Investing Activities -172M USD -79.2%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 260M shares +0.97%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -128M USD -8.48%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 599M USD -14.9%
Deferred Tax Assets, Valuation Allowance 261M USD -15.5%
Deferred Tax Assets, Gross 1.3B USD +10.7%
Operating Lease, Liability 156M USD -8.77%
Depreciation 34M USD +6.25%
Payments to Acquire Property, Plant, and Equipment 32M USD -30.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 740M USD -19.7%
Lessee, Operating Lease, Liability, to be Paid 177M USD -6.35%
Operating Lease, Liability, Current 44M USD -4.35%
Lessee, Operating Lease, Liability, to be Paid, Year Two 34M USD -29.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 49M USD -5.77%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -17M USD -440%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21M USD +16.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 28M USD -3.45%
Deferred Tax Assets, Operating Loss Carryforwards 224M USD +540%
Unrecognized Tax Benefits 121M USD +5.22%
Lessee, Operating Lease, Liability, to be Paid, Year Four 18M USD +28.6%
Deferred Tax Assets, Net of Valuation Allowance 1.04B USD +20%
Share-based Payment Arrangement, Expense 97M USD -10.2%
Interest Expense 513M USD -2.29%